Fund shareholders of Aclaris Therapeutics Inc
ISIN US00461U1051 · United States · LEI 5493000B2LQ9QTW1DF52
- Fund shareholders
- 124
- Of which ETFs
- 20 104 other funds
- Value held
- 60.2M $
- Share of capital
- 11.0 % of 147.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 3,200 | 12K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 3,121 | 9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 3,120 | 11.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 2,996 | 13K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AVIP Fidelity Institutional AM Equity Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 2,837 | 10.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,303 | 8.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,179 | 8.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,045 | 7.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 2,030 | 7.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,400 | 5.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,037 | 4.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 1,000 | 4.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 654 | 2.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 565 | 2.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 463 | 1.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 404 | 1.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 307 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 232 | 870 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 212 | 795 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 167 | 724.8 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 121 | 453.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 94 | 269.8 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 27 | 77.5 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 23 | 86.3 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.66 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.51 % | as of Mar 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.48 % | as of Feb 28, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.20 % | as of Feb 28, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 0.12 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Fund JPMorgan Trust II | 0.09 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund Goldman Sachs Variable Insurance Trust | 0.09 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small Cap Value Portfolio Brighthouse Funds Trust I | 0.09 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 0.09 % | as of Mar 31, 2026 ↗ |
| AQR Small Cap Momentum Style Fund AQR Funds | 0.08 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 124 | +15 | 16,190,248 | +10.1 % |
| 2026Q1 | 109 | +7 | 14,711,205 | +8.0 % |
| 2025Q4 | 102 | +9 | 13,621,630 | +0.8 % |
| 2025Q3 | 93 | +41 | 13,514,466 | +92.4 % |
| 2025Q2 | 52 | +7 | 7,023,353 | +13.8 % |
| 2025Q1 | 45 | +14 | 6,171,153 | -9.7 % |
| 2024Q4 | 31 | -43 | 6,831,305 | -34.4 % |
| 2024Q3 | 74 | -24 | 10,406,179 | -6.5 % |
| 2024Q2 | 98 | -14 | 11,127,126 | -4.9 % |
| 2024Q1 | 112 | -54 | 11,705,314 | -11.5 % |
| 2023Q4 | 166 | 13,222,552 |
Institutional managers
130 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BML Capital Management, LLC | 14,250,000 | 53.4M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 9,345,000 | 35M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,407,065 | 27.8M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 6,804,072 | 25.5M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 6,666,666 | 25M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 4,925,374 | 18.5M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 4,472,650 | 16.8M $ | as of Mar 31, 2026 |
| Decheng Capital LLC | 4,041,736 | 15.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,871,000 | 14.5M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,361,328 | 12.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,746,302 | 10.3M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,423,691 | 9.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,249,319 | 8.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,008,746 | 7.5M $ | as of Mar 31, 2026 |
| Kalehua Capital Management LLC | 1,832,365 | 6.9M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,699,116 | 6.4M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 1,613,430 | 6.1M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 1,539,791 | 5.8K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,485,623 | 5.6M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,418,360 | 5.3M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 997,850 | 3.7M $ | as of Mar 31, 2026 |
| Aldebaran Capital, LLC | 947,162 | 3.6M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 900,804 | 3.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 756,127 | 2.8M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 728,225 | 2.7M $ | as of Mar 31, 2026 |
Declared shareholders of Aclaris Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| BML Investment Partners, L.P. | 9.90 % | 13,950,000 | as of Apr 23, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 6.30 % | 7,626,705 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vivo Opportunity Fund Holdings, L.P. and 3 others | 4.30 % | 5,966,370 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Aclaris Therapeutics Inc". https://titelia.com/en/stocks/aclaris-therapeutics-inc-US00461U1051